Vanguard Fiduciary Trust
AEON icon

Vanguard Fiduciary Trust’s AEON Biopharma AEON Stock Holding History

Vanguard Fiduciary Trust’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.86K Sell
13,713
-989
-7% -$827 ﹤0.01% 4044
2026
Q1 		$14.5K Buy
+14,702
New +$16.4K ﹤0.01% 3975

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust's AEON Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its AEON Biopharma (AEON) stake by 6.7% in Q2 2026, selling an estimated $827 and leaving 13,713 shares worth $9.86K. The position accounts for ﹤0.01% of the portfolio, ranked #4044.

Vanguard Fiduciary Trust first reported a position in AEON in Q1 2026 and has held it in 2 quarters since. The position peaked at $14.5K in Q1 2026. 23 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

  • Vanguard Fiduciary Trust held 13,713 shares of AEON Biopharma worth $9.86K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 989 AEON Biopharma shares in Q2 2026, an estimated $827.
  • AEON Biopharma made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #4044 holding.
  • Vanguard Fiduciary Trust first reported a position in AEON Biopharma in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's AEON Biopharma position peaked at $14.5K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.